Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:23
10/01/21
10/01
16:23
10/01/21
16:23
MRK

Merck

$81.39 /

+6.27 (+8.35%)

, FIVN

Five9

$167.23 /

+7.4 (+4.63%)

, ZM

Zoom Video

$267.57 /

+5.71 (+2.18%)

, GM

General Motors

$53.14 /

+0.44 (+0.83%)

, EA

Electronic Arts

$143.51 /

+1.13 (+0.79%)

, GH

Guardant Health

$107.57 /

-17.53 (-14.01%)

, NEO

NeoGenomics

$48.50 /

+0.21 (+0.43%)

, GOOGL

Alphabet Class A

$2,728.65 /

+55.74 (+2.09%)

, GOOG

Alphabet

$2,725.73 /

+62.66 (+2.35%)

, DIS

Disney

$176.11 /

+6.96 (+4.11%)

, COIN

Coinbase

$231.15 /

+3.69 (+1.62%)

, IBM

IBM

$143.33 /

+4.4 (+3.17%)

, BABA

Alibaba

$144.20 /

-3.84 (-2.59%)

, MGM

MGM Resorts

$44.86 /

+1.72 (+3.99%)

, DKNG

DraftKings

$50.53 /

+2.36 (+4.90%)

, GMVHF

Entain

$29.59 /

-0.212 (-0.71%)

, NFLX

Netflix

$612.88 /

+2.41 (+0.39%)

, DLTR

Dollar Tree

$97.92 /

+2.25 (+2.35%)

, TMC

The Metals Company

$5.17 /

+0.59 (+12.88%)

, VLTA

Volta

$9.39 /

+0.76 (+8.81%)

, OMER

Omeros

$8.54 /

-5.285 (-38.24%)

, CGC

Canopy Growth

$13.41 /

-0.44 (-3.18%)

, QUIK

QuickLogic

$5.80 /

+0.48 (+9.02%)

, GWRE

Guidewire

$118.54 /

-0.61 (-0.51%)

, ALLE

Allegion

$132.42 /

+0.23 (+0.17%)

, COTY

Coty

$8.18 /

+0.325 (+4.14%)

, KKR

KKR

$61.67 /

+0.76 (+1.25%)

, MRNA

Moderna

$340.38 /

-44.76 (-11.62%)

, PFE

Pfizer

$42.93 /

-0.07 (-0.16%)

, ABCL

AbCellera

$17.20 /

-2.87 (-14.30%)

, ADGI

Adagio Therapeutics

$28.03 /

-13.98 (-33.28%)

, AAL

American Airlines

$21.64 /

+1.13 (+5.51%)

, UAL

United Airlines

$51.33 /

+3.72 (+7.81%)

, DAL

Delta Air Lines

$45.38 /

+2.77 (+6.50%)

, LUV

Southwest

$54.37 /

+2.94 (+5.72%)

, JBLU

JetBlue

$16.30 /

+1.02 (+6.68%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

VLTA Volta
$9.39 /

+0.76 (+8.81%)

UAL United Airlines
$51.33 /

+3.72 (+7.81%)

TMC The Metals Company
$5.17 /

+0.59 (+12.88%)

QUIK QuickLogic
$5.80 /

+0.48 (+9.02%)

PFE Pfizer
$42.93 /

-0.07 (-0.16%)

OMER Omeros
$8.54 /

-5.285 (-38.24%)

NFLX Netflix
$612.88 /

+2.41 (+0.39%)

NEO NeoGenomics
$48.50 /

+0.21 (+0.43%)

MRNA Moderna
$340.38 /

-44.76 (-11.62%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

LUV Southwest
$54.37 /

+2.94 (+5.72%)

KKR KKR
$61.67 /

+0.76 (+1.25%)

JBLU JetBlue
$16.30 /

+1.02 (+6.68%)

IBM IBM
$143.33 /

+4.4 (+3.17%)

GWRE Guidewire
$118.54 /

-0.61 (-0.51%)

GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

GOOG Alphabet
$2,725.73 /

+62.66 (+2.35%)

GMVHF Entain
$29.59 /

-0.212 (-0.71%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

GH Guardant Health
$107.57 /

-17.53 (-14.01%)

FIVN Five9
$167.23 /

+7.4 (+4.63%)

EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

DIS Disney
$176.11 /

+6.96 (+4.11%)

DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

COTY Coty
$8.18 /

+0.325 (+4.14%)

COIN Coinbase
$231.15 /

+3.69 (+1.62%)

CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

BABA Alibaba
$144.20 /

-3.84 (-2.59%)

ALLE Allegion
$132.42 /

+0.23 (+0.17%)

ADGI Adagio Therapeutics
$28.03 /

-13.98 (-33.28%)

ABCL AbCellera
$17.20 /

-2.87 (-14.30%)

AAL American Airlines
$21.64 /

+1.13 (+5.51%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
10/01/21 Piper Sandler
Piper says view on Regeneron antibody 'less certain' after Merck 'game changer'
10/01/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis, thinks involved on Merck COVID pill
10/01/21 Benchmark
Codexis spike due to speculation related to Merck COVID pill, says Benchmark
FIVN Five9
$167.23 /

+7.4 (+4.63%)

10/01/21 Northland
Five9 upgraded to Outperform from Market Perform at Northland
10/01/21 Colliers
Five9 upgraded to Buy from Neutral at Colliers
10/01/21 Canaccord
Canaccord upgrades Five9 to Buy, sees opportunity in deal termination
10/01/21 Evercore ISI
Evercore ISI upgrades Five9 to Outperform after Zoom deal break
ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

10/01/21 Credit Suisse
GM investor day to highlight growth opportunities, says Credit Suisse
09/26/21 Goldman Sachs
General Motors price target lowered to $59 from $62 at Goldman Sachs
09/24/21 Citi
GM investor day could be 'significant positive catalyst,' says Citi
09/13/21 Barclays
General Motors price target lowered to $68 from $71 at Barclays
EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
GH Guardant Health
$107.57 /

-17.53 (-14.01%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
NEO NeoGenomics
$48.50 /

+0.21 (+0.43%)

08/26/21 Benchmark
NeoGenomics price target raised to $50 from $46 at Benchmark
06/03/21 Goldman Sachs
NeoGenomics initiated with a Buy at Goldman Sachs
05/25/21 Truist
NeoGenomics price target lowered to $54 from $65 at Truist
02/25/21 Craig-Hallum
NeoGenomics price target raised to $65 from $50 at Craig-Hallum
GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

09/30/21 RBC Capital
Alphabet initiated with an Outperform at RBC Capital
09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/17/21 Jefferies
Alphabet price target raised to $3,325 from $3,150 at Jefferies
09/13/21
Fly Intel: Top five analyst initiations
GOOG Alphabet
$2,725.73 /

+62.66 (+2.35%)

09/13/21 Goldman Sachs
Alphabet Class A initiated with a Buy at Goldman Sachs
DIS Disney
$176.11 /

+6.96 (+4.11%)

09/28/21 Wells Fargo
Wells Fargo cuts Disney target, sees 'wood to chop' to hit sub outlook
09/22/21 BofA
Disney's Q4 Disney+ subscriber adds estimate cut to 2M from 14M at BofA
09/21/21 KeyBanc
Disney+ subscriber guidance 'a very modest incremental negative,' says KeyBanc
09/21/21 Daiwa
Disney initiated with a Buy at Daiwa
COIN Coinbase
$231.15 /

+3.69 (+1.62%)

09/28/21
Fly Intel: Top five analyst initiations
09/28/21 JMP Securities
Coinbase initiated with an Outperform at JMP Securities
09/14/21 Piper Sandler
Coinbase recent selloff overdone, says Piper Sandler
09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
IBM IBM
$143.33 /

+4.4 (+3.17%)

10/01/21
Fly Intel: Top five analyst initiations
10/01/21 Jefferies
IBM initiated with a Buy at Jefferies
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Morgan Stanley
IBM price target raised to $164 from $152 at Morgan Stanley
BABA Alibaba
$144.20 /

-3.84 (-2.59%)

10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 KeyBanc
Alibaba price target lowered to $200 from $250 at KeyBanc
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

10/01/21 Susquehanna
Susquehanna cuts MGM to Negative on digital prospects hit from DraftKings bid
10/01/21 Susquehanna
MGM Resorts downgraded to Negative from Neutral at Susquehanna
09/24/21 Credit Suisse
As Macau locks down, Credit Suisse warns of downside risk to 2022 GGR estimates
DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

09/22/21 Craig-Hallum
Craig-Hallum says DraftKings deal outcome 'unanimously negative for competitors'
09/21/21 Jefferies
Jefferies sees takeout value for Entain at least GBp 2,820 per share
GMVHF Entain
$29.59 /

-0.212 (-0.71%)

09/23/21 JPMorgan
Entain price target raised to 2,570 GBp from 2,450 GBp at JPMorgan
NFLX Netflix
$612.88 /

+2.41 (+0.39%)

10/01/21 Guggenheim
Netflix price target raised to $685 from $600 at Guggenheim
09/29/21 KeyBanc
Netflix content resonating with users, says KeyBanc
09/29/21 Benchmark
Netflix price target raised to $493 from $448 at Benchmark
09/28/21 Evercore ISI
Four of top 10 most popular Netflix shows have releases in Q4, says Evercore ISI
DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

10/01/21 KeyBanc
Dollar Tree downgraded to Sector Weight from Overweight at KeyBanc
09/30/21 KeyBanc
Dollar Tree downgraded to Sector Weight from Overweight at KeyBanc
09/29/21 Jefferies
Added price points could have multiple benefits for Dollar Tree, says Jefferies
08/27/21 Telsey Advisory
Telsey downgrades Dollar Tree on inability to pass on higher costs
TMC The Metals Company
$5.17 /

+0.59 (+12.88%)

05/27/21 Northland
Sustainable Opportunities Acquisition initiated with an Outperform at Northland
VLTA Volta
$9.39 /

+0.76 (+8.81%)

10/01/21 Roth Capital
Volta initiated with a Buy at Roth Capital
09/22/21 Needham
Volta initiated with a Buy at Needham
09/01/21 Raymond James
Volta's adjusted EBITDA should turn positive in 2023, says Raymond James
09/01/21 Raymond James
Volta initiated with an Outperform at Raymond James
OMER Omeros
$8.54 /

-5.285 (-38.24%)

10/01/21 Wedbush
Omeros downgraded to Underperform at Wedbush after 'major setback'
10/01/21 Wedbush
Omeros downgraded to Underperform from Neutral at Wedbush
10/01/21 Maxim
Omeros downgraded to Hold from Buy at Maxim
09/27/21 JPMorgan
Omeros initiated with a Neutral at JPMorgan
CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

10/01/21 BofA
Canopy Growth downgraded to Neutral at BofA on near-term sales risk
10/01/21 BofA
Canopy Growth downgraded to Neutral from Buy at BofA
09/23/21 CIBC
Canopy Growth price target lowered to C$22 from C$27 at CIBC
QUIK QuickLogic
$5.80 /

+0.48 (+9.02%)

05/19/21 Roth Capital
QuickLogic upgraded to Buy from Neutral at Roth Capital
GWRE Guidewire
$118.54 /

-0.61 (-0.51%)

09/03/21 JPMorgan
Guidewire price target raised to $160 from $145 at JPMorgan
09/03/21 BTIG
Guidewire price target raised to $138 from $130 at BTIG
09/03/21 Citi
Guidewire price target raised to $138 from $115 at Citi
07/16/21 Stifel
Guidewire transferred with Hold rating at Stifel
ALLE Allegion
$132.42 /

+0.23 (+0.17%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Goldman Sachs
Allegion upgraded to Buy from Neutral at Goldman Sachs
07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
COTY Coty
$8.18 /

+0.325 (+4.14%)

09/09/21 Deutsche Bank
Coty secondary offering sends 'negative signal,' says Deutsche Bank
08/27/21 Deutsche Bank
Coty price target raised to $10 from $9 at Deutsche Bank
08/27/21 Wells Fargo
Coty price target raised to $8 from $6 at Wells Fargo
08/18/21 Stifel
Ulta Beauty price target raised to $385 from $330 at Stifel
KKR KKR
$61.67 /

+0.76 (+1.25%)

09/13/21 Citi
Citi ups KKR target to Street-high, opens 'Positive Catalyst Watch"
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
08/11/21 Deutsche Bank
KKR upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
KKR upgraded to Buy from Hold at Deutsche Bank
MRNA Moderna
$340.38 /

-44.76 (-11.62%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
PFE Pfizer
$42.93 /

-0.07 (-0.16%)

09/27/21 Barrington
Barrington says Somatrogon delay does not change Opko Health view
09/24/21 Piper Sandler
Piper confident in Opko's somatrogon approval despite BLA review delay
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
ABCL AbCellera
$17.20 /

-2.87 (-14.30%)

10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
ADGI Adagio Therapeutics
$28.03 /

-13.98 (-33.28%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
AAL American Airlines
$21.64 /

+1.13 (+5.51%)

08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
07/27/21 Susquehanna
American Airlines upgraded to Neutral at Susquehanna
07/27/21 Susquehanna
American Airlines upgraded to Neutral from Negative at Susquehanna
UAL United Airlines
$51.33 /

+3.72 (+7.81%)

08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
07/13/21
Fly Intel: Top five analyst downgrades
DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

09/24/21 Deutsche Bank
Delta Air Lines named short-term buy idea at Deutsche Bank
09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 Argus
Delta Air Lines downgraded to Hold from Buy at Argus
09/23/21 Argus
Delta Air Lines downgraded to Hold from Buy at Argus
LUV Southwest
$54.37 /

+2.94 (+5.72%)

10/01/21
Fly Intel: Top five analyst upgrades
10/01/21 JPMorgan
Southwest upgraded to Overweight with $70 target at JPMorgan
10/01/21 JPMorgan
Southwest upgraded to Overweight from Neutral at JPMorgan
JBLU JetBlue
$16.30 /

+1.02 (+6.68%)

07/28/21 Susquehanna
JetBlue price target lowered to $21 from $24 at Susquehanna
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
04/15/21 Barclays
JetBlue price target raised to $20 from $14 at Barclays
ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

UAL United Airlines
$51.33 /

+3.72 (+7.81%)

QUIK QuickLogic
$5.80 /

+0.48 (+9.02%)

PFE Pfizer
$42.93 /

-0.07 (-0.16%)

OMER Omeros
$8.54 /

-5.285 (-38.24%)

NFLX Netflix
$612.88 /

+2.41 (+0.39%)

MRNA Moderna
$340.38 /

-44.76 (-11.62%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

LUV Southwest
$54.37 /

+2.94 (+5.72%)

KKR KKR
$61.67 /

+0.76 (+1.25%)

JBLU JetBlue
$16.30 /

+1.02 (+6.68%)

IBM IBM
$143.33 /

+4.4 (+3.17%)

GWRE Guidewire
$118.54 /

-0.61 (-0.51%)

GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

GH Guardant Health
$107.57 /

-17.53 (-14.01%)

FIVN Five9
$167.23 /

+7.4 (+4.63%)

EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

DIS Disney
$176.11 /

+6.96 (+4.11%)

DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

COTY Coty
$8.18 /

+0.325 (+4.14%)

COIN Coinbase
$231.15 /

+3.69 (+1.62%)

CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

BABA Alibaba
$144.20 /

-3.84 (-2.59%)

ALLE Allegion
$132.42 /

+0.23 (+0.17%)

ADGI Adagio Therapeutics
$28.03 /

-13.98 (-33.28%)

ABCL AbCellera
$17.20 /

-2.87 (-14.30%)

AAL American Airlines
$21.64 /

+1.13 (+5.51%)

  • 08
    Sep
  • 06
    Aug
  • 14
    Apr
  • 13
    Jan
  • 07
    Jan
  • 11
    Dec
  • 02
    Dec
  • 11
    Nov
  • 10
    Nov
  • 07
    Oct
  • 07
    Oct
ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

UAL United Airlines
$51.33 /

+3.72 (+7.81%)

PFE Pfizer
$42.93 /

-0.07 (-0.16%)

NFLX Netflix
$612.88 /

+2.41 (+0.39%)

NEO NeoGenomics
$48.50 /

+0.21 (+0.43%)

MRNA Moderna
$340.38 /

-44.76 (-11.62%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

LUV Southwest
$54.37 /

+2.94 (+5.72%)

KKR KKR
$61.67 /

+0.76 (+1.25%)

IBM IBM
$143.33 /

+4.4 (+3.17%)

GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

GH Guardant Health
$107.57 /

-17.53 (-14.01%)

FIVN Five9
$167.23 /

+7.4 (+4.63%)

EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

DIS Disney
$176.11 /

+6.96 (+4.11%)

DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

COTY Coty
$8.18 /

+0.325 (+4.14%)

COIN Coinbase
$231.15 /

+3.69 (+1.62%)

CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

BABA Alibaba
$144.20 /

-3.84 (-2.59%)

AAL American Airlines
$21.64 /

+1.13 (+5.51%)

ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

VLTA Volta
$9.39 /

+0.76 (+8.81%)

UAL United Airlines
$51.33 /

+3.72 (+7.81%)

TMC The Metals Company
$5.17 /

+0.59 (+12.88%)

PFE Pfizer
$42.93 /

-0.07 (-0.16%)

NFLX Netflix
$612.88 /

+2.41 (+0.39%)

MRNA Moderna
$340.38 /

-44.76 (-11.62%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

IBM IBM
$143.33 /

+4.4 (+3.17%)

GWRE Guidewire
$118.54 /

-0.61 (-0.51%)

GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

GMVHF Entain
$29.59 /

-0.212 (-0.71%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

GH Guardant Health
$107.57 /

-17.53 (-14.01%)

FIVN Five9
$167.23 /

+7.4 (+4.63%)

EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

DIS Disney
$176.11 /

+6.96 (+4.11%)

DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

COTY Coty
$8.18 /

+0.325 (+4.14%)

COIN Coinbase
$231.15 /

+3.69 (+1.62%)

CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

BABA Alibaba
$144.20 /

-3.84 (-2.59%)

ADGI Adagio Therapeutics
$28.03 /

-13.98 (-33.28%)

ABCL AbCellera
$17.20 /

-2.87 (-14.30%)

AAL American Airlines
$21.64 /

+1.13 (+5.51%)

ZM Zoom Video
$267.57 /

+5.71 (+2.18%)

VLTA Volta
$9.39 /

+0.76 (+8.81%)

UAL United Airlines
$51.33 /

+3.72 (+7.81%)

TMC The Metals Company
$5.17 /

+0.59 (+12.88%)

PFE Pfizer
$42.93 /

-0.07 (-0.16%)

NFLX Netflix
$612.88 /

+2.41 (+0.39%)

MRNA Moderna
$340.38 /

-44.76 (-11.62%)

MRK Merck
$81.39 /

+6.27 (+8.35%)

MGM MGM Resorts
$44.86 /

+1.72 (+3.99%)

LUV Southwest
$54.37 /

+2.94 (+5.72%)

KKR KKR
$61.67 /

+0.76 (+1.25%)

JBLU JetBlue
$16.30 /

+1.02 (+6.68%)

IBM IBM
$143.33 /

+4.4 (+3.17%)

GOOGL Alphabet Class A
$2,728.65 /

+55.74 (+2.09%)

GM General Motors
$53.14 /

+0.44 (+0.83%)

EA Electronic Arts
$143.51 /

+1.13 (+0.79%)

DLTR Dollar Tree
$97.92 /

+2.25 (+2.35%)

DKNG DraftKings
$50.53 /

+2.36 (+4.90%)

DIS Disney
$176.11 /

+6.96 (+4.11%)

DAL Delta Air Lines
$45.38 /

+2.77 (+6.50%)

COTY Coty
$8.18 /

+0.325 (+4.14%)

COIN Coinbase
$231.15 /

+3.69 (+1.62%)

CGC Canopy Growth
$13.41 /

-0.44 (-3.18%)

BABA Alibaba
$144.20 /

-3.84 (-2.59%)

ABCL AbCellera
$17.20 /

-2.87 (-14.30%)

AAL American Airlines
$21.64 /

+1.13 (+5.51%)

Recommendations
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel » 09:59
10/01/21
10/01
09:59
10/01/21
09:59
ABCL

AbCellera

$18.10 /

-1.97 (-9.82%)

, ADGI

Adagio Therapeutics

$26.49 /

-15.52 (-36.94%)

, MRK

Merck

$81.10 /

+5.98 (+7.96%)

Stifel analyst Stephen…

Stifel analyst Stephen Willey notes that Adagio Therapeutics (ADGI) and AbCellera Biologics (ABCL) are lower on competitive concerns after Merck (MRK) and partner Ridgeback announced that their oral antiviral molnupiravir achieved the threshold for statistical significance in an interim analysis of the global Phase 3 MOVe-OUT trial evaluating the drug in patients with laboratory-confirmed, mild-to-moderate COVID-19. Merck is "astonishingly" adding about $15B in market cap this morning despite the implied risk reduction associated with molnupiravir in MOVe-OUT representing "a fraction of the 70-87% risk reductions observed with other COVID mAb therapies already granted EUAs," said Willey. He views Adagio's ADG20 to have a best-in-class profile amongst the COVID monoclonal antibody therapeutics in terms of both "clinical and logistical advantages," Willey said. He also believes any weakness in AbCellera shares "appears completely unfounded," as he argues that the COVID opportunity "has been seemingly washed out of the stock at current levels." Willey has Buy ratings on both Adagio and AbCellera shares, which are down 36% and 10%, respectively, in Friday morning trading.

ShowHide Related Items >><<
MRK Merck
$81.10 /

+5.98 (+7.96%)

ADGI Adagio Therapeutics
$26.49 /

-15.52 (-36.94%)

ABCL AbCellera
$18.10 /

-1.97 (-9.82%)

ABCL AbCellera
$18.10 /

-1.97 (-9.82%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
ADGI Adagio Therapeutics
$26.49 /

-15.52 (-36.94%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
08/31/21 Jefferies
Adagio Therapeutics initiated with a Buy at Jefferies
MRK Merck
$81.10 /

+5.98 (+7.96%)

10/01/21 Citi
Merck shares to benefit 'very significantly' from Covid data, says Citi
09/30/21 Cowen
Acceleron downgraded to Market Perform from Outperform at Cowen
09/30/21 H.C. Wainwright
Acceleron downgraded to Neutral from Buy at H.C. Wainwright
09/30/21 Piper Sandler
Acceleron downgraded to Neutral from Overweight at Piper Sandler
MRK Merck
$81.10 /

+5.98 (+7.96%)

ADGI Adagio Therapeutics
$26.49 /

-15.52 (-36.94%)

ABCL AbCellera
$18.10 /

-1.97 (-9.82%)

  • 06
    Aug
  • 11
    Dec
MRK Merck
$81.10 /

+5.98 (+7.96%)

MRK Merck
$81.10 /

+5.98 (+7.96%)

ADGI Adagio Therapeutics
$26.49 /

-15.52 (-36.94%)

ABCL AbCellera
$18.10 /

-1.97 (-9.82%)

MRK Merck
$81.10 /

+5.98 (+7.96%)

ABCL AbCellera
$18.10 /

-1.97 (-9.82%)

Over a month ago
Hot Stocks
AbCellera, Everest Medicines announce multi-target collaboration » 18:02
09/22/21
09/22
18:02
09/22/21
18:02
ABCL

AbCellera

$21.34 /

+0.265 (+1.26%)

AbCellera and Everest…

AbCellera and Everest Medicines have entered into a multi-year collaboration and license agreement to discover therapeutic antibodies for up to 10 targets selected by Everest. The partnership will help to expand Everest's portfolio of novel medicines across multiple indications, with the initial programs focusing on targets in oncology. The collaboration will leverage AbCellera's technology stack, including sourcing fully humanized antibodies from the Trianni Mouse, sourcing single domain antibodies from camelids, and combining any two antibodies to create native bispecifics using the OrthoMabTM protein engineering platform. Everest will have the rights to develop and commercialize antibodies resulting from the collaboration. AbCellera will receive research payments and is eligible to receive from Everest downstream clinical and commercial milestone payments and royalties on net sales of products.

ShowHide Related Items >><<
ABCL AbCellera
$21.34 /

+0.265 (+1.26%)

ABCL AbCellera
$21.34 /

+0.265 (+1.26%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
ABCL AbCellera
$21.34 /

+0.265 (+1.26%)

  • 11
    Dec
ABCL AbCellera
$21.34 /

+0.265 (+1.26%)

ABCL AbCellera
$21.34 /

+0.265 (+1.26%)

Hot Stocks
AbCellera notes Lilly to supply EU, EEA with up to 220,000 antibody combo doses » 13:58
09/21/21
09/21
13:58
09/21/21
13:58
ABCL

AbCellera

$20.54 /

-0.08 (-0.39%)

, LLY

Eli Lilly

$230.09 /

-1.65 (-0.71%)

AbCellera (ABCL)…

AbCellera (ABCL) announced the European Commission and Eli Lilly (LLY) have entered into a Joint Procurement Agreement to supply up to 220,000 doses of bamlanivimab together with etesevimab to treat confirmed COVID-19 in patients aged 12 years and older that do not require supplemental oxygen for COVID-19 and who are at increased risk of progressing to severe COVID-19. The agreement helps to provide access to treatments by enabling participating countries in the European Union and European Economic Area to purchase the products directly from Lilly following national approval for emergency use or marketing authorization at the EU level. "AbCellera's ongoing efforts to respond to the COVID-19 pandemic have identified thousands of unique anti-SARS-CoV-2 human antibodies. These include bamlanivimab, bebtelovimab, and other antibodies that are in various stages of testing by AbCellera and its partners," the company stated.

ShowHide Related Items >><<
LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

ABCL AbCellera
$20.54 /

-0.08 (-0.39%)

ABCL AbCellera
$20.54 /

-0.08 (-0.39%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

ABCL AbCellera
$20.54 /

-0.08 (-0.39%)

  • 11
    Dec
LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

ABCL AbCellera
$20.54 /

-0.08 (-0.39%)

LLY Eli Lilly
$230.09 /

-1.65 (-0.71%)

ABCL AbCellera
$20.54 /

-0.08 (-0.39%)

Options
Unusually active option classes on open September 17th » 09:40
09/17/21
09/17
09:40
09/17/21
09:40
DJX

Dow Jones Industrial Average

/

+

, ABCL

AbCellera

$19.80 /

+0.015 (+0.08%)

, HYRE

HyreCar

$9.71 /

+ (+0.00%)

, ASTS

AST SpaceMobile

$11.67 /

+ (+0.00%)

, BITF

Bitfarms

$5.31 /

+ (+0.00%)

, LCID

Lucid Group

$21.19 /

-0.01 (-0.05%)

, XLE

Energy Select Sector SPDR

$49.70 /

+ (+0.00%)

, DNN

Denison Mines

$1.70 /

+ (+0.00%)

, SOXL

Direxion Daily Semiconductor Bull 3X Shares

$48.99 /

+ (+0.00%)

, VALE

Vale

$16.72 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: DJIA (.DJX), AbCellera Biologics (ABCL), HyreCar (HYRE), AST SpaceMobile (ASTS), Bitfarms (BITF), Lucid Group (LCID), Energy Sector SPDR ETF (XLE), Denison Mines (DNN), Direxion Daily Semiconductor Bull 3X Shares (SOXL), and Vale (VALE).

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$49.70 /

+ (+0.00%)

VALE Vale
$16.72 /

+ (+0.00%)

LCID Lucid Group
$21.19 /

-0.01 (-0.05%)

HYRE HyreCar
$9.71 /

+ (+0.00%)

DNN Denison Mines
$1.70 /

+ (+0.00%)

DJX Dow Jones Industrial Average
/

+

BITF Bitfarms
$5.31 /

+ (+0.00%)

ASTS AST SpaceMobile
$11.67 /

+ (+0.00%)

ABCL AbCellera
$19.80 /

+0.015 (+0.08%)

DJX Dow Jones Industrial Average
/

+

ABCL AbCellera
$19.80 /

+0.015 (+0.08%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
HYRE HyreCar
$9.71 /

+ (+0.00%)

08/11/21
Fly Intel: Top five analyst downgrades
08/11/21 DA Davidson
HyreCar price target lowered to $22 from $25 at DA Davidson
08/11/21 Ladenburg
HyreCar downgraded to Neutral at Ladenburg after 'messy' Q2
08/11/21 Ladenburg
HyreCar downgraded to Neutral from Buy at Ladenburg
ASTS AST SpaceMobile
$11.67 /

+ (+0.00%)

07/12/21 Barclays
AST SpaceMobile initiated with an Overweight at Barclays
06/30/21 Deutsche Bank
AST SpaceMobile initiated with a Buy at Deutsche Bank
BITF Bitfarms
$5.31 /

+ (+0.00%)

LCID Lucid Group
$21.19 /

-0.01 (-0.05%)

09/17/21 Morgan Stanley
520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley
09/15/21 BofA
BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy
09/15/21 BofA
Lucid Group initiated with a Buy at BofA
09/13/21 Morgan Stanley
Lucid Group initiated with an Underweight at Morgan Stanley
XLE Energy Select Sector SPDR
$49.70 /

+ (+0.00%)

07/21/21 Goldman Sachs
Halliburton upgraded to Buy from Neutral at Goldman Sachs
03/12/21
On The Fly: Weekly technical notes for S&P 500
DNN Denison Mines
$1.70 /

+ (+0.00%)

09/15/21 TD Securities
Denison Mines price target raised to C$2.40 from C$1.65 at TD Securities
09/07/21 Raymond James
Denison Mines price target raised to C$2.10 from C$1.80 at Raymond James
08/16/21 TD Securities
Denison Mines price target raised to C$1.65 from C$1.55 at TD Securities
08/05/21 Raymond James
Denison Mines upgraded to Outperform from Market Perform at Raymond James
SOXL Direxion Daily Semiconductor Bull 3X Shares
$48.99 /

+ (+0.00%)

VALE Vale
$16.72 /

+ (+0.00%)

09/17/21 UBS
Vale downgraded to Sell from Buy at UBS
07/15/21 HSBC
Vale price target raised to $27 from $25 at HSBC
07/12/21 Scotiabank
Vale price target raised to $26 from $24 at Scotiabank
07/02/21 RBC Capital
Vale price target lowered to $27 from $29 at RBC Capital
VALE Vale
$16.72 /

+ (+0.00%)

HYRE HyreCar
$9.71 /

+ (+0.00%)

ABCL AbCellera
$19.80 /

+0.015 (+0.08%)

  • 04
    Feb
  • 11
    Dec
VALE Vale
$16.72 /

+ (+0.00%)

LCID Lucid Group
$21.19 /

-0.01 (-0.05%)

LCID Lucid Group
$21.19 /

-0.01 (-0.05%)

HYRE HyreCar
$9.71 /

+ (+0.00%)

ASTS AST SpaceMobile
$11.67 /

+ (+0.00%)

ABCL AbCellera
$19.80 /

+0.015 (+0.08%)

VALE Vale
$16.72 /

+ (+0.00%)

SOXL Direxion Daily Semiconductor Bull 3X Shares
$48.99 /

+ (+0.00%)

LCID Lucid Group
$21.19 /

-0.01 (-0.05%)

HYRE HyreCar
$9.71 /

+ (+0.00%)

DNN Denison Mines
$1.70 /

+ (+0.00%)

DJX Dow Jones Industrial Average
/

+

BITF Bitfarms
$5.31 /

+ (+0.00%)

ASTS AST SpaceMobile
$11.67 /

+ (+0.00%)

ABCL AbCellera
$19.80 /

+0.015 (+0.08%)

XLE Energy Select Sector SPDR
$49.70 /

+ (+0.00%)

DJX Dow Jones Industrial Average
/

+

On The Fly
Fly Intel: Pre-market Movers » 08:53
09/17/21
09/17
08:53
09/17/21
08:53
IPHA

Innate Pharma

$5.76 /

+0.26 (+4.73%)

, ABCL

AbCellera

$19.80 /

+1.03 (+5.49%)

, IVZ

Invesco

$24.88 /

-0.67 (-2.62%)

, BGNE

BeiGene

$385.26 /

+10.94 (+2.92%)

, BPTS

Biophytis

$8.90 /

+0.05 (+0.56%)

, MANU

Manchester United

$17.65 /

+0.105 (+0.60%)

, PTGX

Protagonist Therapeutics

$45.96 /

-0.44 (-0.95%)

, OPAD

Offerpad Solutions

$20.17 /

+7.395 (+57.89%)

, TTWO

Take-Two

$151.89 /

-0.78 (-0.51%)

, STT

State Street

$87.03 /

-0.9 (-1.02%)

Check out this morning's…

ShowHide Related Items >><<
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
IVZ Invesco
$24.88 /

-0.67 (-2.62%)

09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
07/12/21 Citi
Invesco upgraded to Buy from Neutral at Citi
BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/30/21 Piper Sandler
Protagonist Therapeutics price target raised to $93 from $53 at Piper Sandler
06/18/21 H.C. Wainwright
Protagonist price target raised to $50 from $36 at H.C. Wainwright
OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
STT State Street
$87.03 /

-0.9 (-1.02%)

09/09/21 JPMorgan
JPMorgan expects 'sizable equity issue' from State Street after deal
09/08/21 Jefferies
State Street pullback on BBH deal a buying opportunity, says Jefferies
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

  • 10
    Sep
  • 16
    Jun
  • 12
    Mar
  • 10
    Feb
  • 11
    Dec
  • 11
    Dec
  • 02
    Dec
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

On The Fly
Fly Intel: After-Hours Movers » 19:03
09/16/21
09/16
19:03
09/16/21
19:03
ABCL

AbCellera

$19.80 /

+1.03 (+5.49%)

, FANG

Diamondback Energy

$79.98 /

-1.63 (-2.00%)

, AGEN

Agenus

$5.57 /

+0.19 (+3.53%)

, CVGW

Calavo Growers

$36.64 /

+1.72 (+4.93%)

, OPAD

Offerpad Solutions

$20.17 /

+7.395 (+57.89%)

, IRNT

IronNet

$41.31 /

+9.255 (+28.87%)

, USNA

Usana

$87.51 /

+0.085 (+0.10%)

, X

U.S. Steel

$25.40 /

-0.27 (-1.05%)

Check out this evening's…

ShowHide Related Items >><<
X U.S. Steel
$25.40 /

-0.27 (-1.05%)

USNA Usana
$87.51 /

+0.085 (+0.10%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

IRNT IronNet
$41.31 /

+9.255 (+28.87%)

FANG Diamondback Energy
$79.98 /

-1.63 (-2.00%)

CVGW Calavo Growers
$36.64 /

+1.72 (+4.93%)

AGEN Agenus
$5.57 /

+0.19 (+3.53%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
FANG Diamondback Energy
$79.98 /

-1.63 (-2.00%)

09/15/21 Truist
Diamondback Energy price target raised to $130 from $122 at Truist
07/22/21 Piper Sandler
Diamondback Energy price target raised to $112 from $102 at Piper Sandler
07/15/21 Mizuho
Diamondback Energy price target raised to $131 from $120 at Mizuho
07/07/21 Wells Fargo
Diamondback Energy price target raised to $101 from $90 at Wells Fargo
AGEN Agenus
$5.57 /

+0.19 (+3.53%)

09/07/21 B. Riley
Agenus price target raised to $12 from $11 at B. Riley
06/28/21 B. Riley
Agenus price target raised to $11 from $8 at B. Riley
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
CVGW Calavo Growers
$36.64 /

+1.72 (+4.93%)

09/09/21 Lake Street
Calavo Growers price target lowered to $60 from $70 at Lake Street
08/05/21 Lake Street
Calavo Growers price target lowered to $70 from $85 at Lake Street
06/04/21 Lake Street
Calavo Growers assumed with a Buy at Lake Street
03/11/21 Lake Street
Calavo Growers price target raised to $73 from $62 at Lake Street
OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

IRNT IronNet
$41.31 /

+9.255 (+28.87%)

USNA Usana
$87.51 /

+0.085 (+0.10%)

02/10/21 Roth Capital
Usana price target raised to $126 from $107 at Roth Capital
12/17/20 Roth Capital
Usana initiated with a Buy at Roth Capital
X U.S. Steel
$25.40 /

-0.27 (-1.05%)

09/15/21 Deutsche Bank
U.S. Steel price target raised to $50 from $38 at Deutsche Bank
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
U.S. Steel price target raised to $38 from $30 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst downgrades
X U.S. Steel
$25.40 /

-0.27 (-1.05%)

USNA Usana
$87.51 /

+0.085 (+0.10%)

FANG Diamondback Energy
$79.98 /

-1.63 (-2.00%)

CVGW Calavo Growers
$36.64 /

+1.72 (+4.93%)

AGEN Agenus
$5.57 /

+0.19 (+3.53%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

  • 03
    Feb
  • 11
    Dec
X U.S. Steel
$25.40 /

-0.27 (-1.05%)

X U.S. Steel
$25.40 /

-0.27 (-1.05%)

IRNT IronNet
$41.31 /

+9.255 (+28.87%)

CVGW Calavo Growers
$36.64 /

+1.72 (+4.93%)

AGEN Agenus
$5.57 /

+0.19 (+3.53%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

X U.S. Steel
$25.40 /

-0.27 (-1.05%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

IRNT IronNet
$41.31 /

+9.255 (+28.87%)

FANG Diamondback Energy
$79.98 /

-1.63 (-2.00%)

AGEN Agenus
$5.57 /

+0.19 (+3.53%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

Hot Stocks
FDA expands AbCellera's EUA for bamlanivimab in COVID prevention » 16:19
09/16/21
09/16
16:19
09/16/21
16:19
ABCL

AbCellera

$19.80 /

+1.03 (+5.49%)

The company states:…

The company states: "AbCellera announced the FDA has expanded the Emergency Use Authorization for bamlanivimab 700 mg administered with etesevimab, or LY-CoV016, 1400 mg to include post-exposure prophylaxis to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison. The expanded EUA is based on data from the Phase 3 BLAZE-2 trial that showed bamlanivimab prevented COVID-19 in nursing homes, reducing the risk of contracting the disease by up to 80 percent in nursing home residents and up to 57 percent among residents and staff of long-term care facilities. Eli Lilly and Company's study was conducted in partnership with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the COVID-19 Prevention Network."

ShowHide Related Items >><<
ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

  • 11
    Dec
ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

Hot Stocks
AbCellera in pact with Moderna to find therapeutic antibodies for mRNA medicines » 09:08
09/15/21
09/15
09:08
09/15/21
09:08
ABCL

AbCellera

$17.56 /

-0.19 (-1.07%)

, MRNA

Moderna

$427.66 /

+8.15 (+1.94%)

AbCellera (ABCL)…

AbCellera (ABCL) announced that it entered into a multi-year, multi-target research collaboration and license agreement with Moderna (MRNA) to leverage AbCellera's AI-powered technology to search and analyze natural immune responses to identify therapeutic antibodies against up to six targets selected by Moderna. "Over the past year, Moderna has demonstrated the speed and impact of its mRNA vaccine technology in helping to protect people around the world," said Carl Hansen, Ph.D., CEO and President of AbCellera. "We are excited to work alongside their team to advance RNA-encoded antibodies as a new frontier in genetic medicines." Under the terms of the agreement, Moderna will have the rights to develop and commercialize antibodies resulting from the collaboration. AbCellera will receive research payments and is eligible to receive from Moderna downstream clinical and commercial milestone payments and royalties on net sales of products.

ShowHide Related Items >><<
MRNA Moderna
$427.66 /

+8.15 (+1.94%)

ABCL AbCellera
$17.56 /

-0.19 (-1.07%)

ABCL AbCellera
$17.56 /

-0.19 (-1.07%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
MRNA Moderna
$427.66 /

+8.15 (+1.94%)

08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
08/06/21 Oppenheimer
Moderna downgraded to Perform from Outperform at Oppenheimer
08/06/21 Piper Sandler
Moderna downgraded to Neutral from Overweight at Piper Sandler
MRNA Moderna
$427.66 /

+8.15 (+1.94%)

ABCL AbCellera
$17.56 /

-0.19 (-1.07%)

  • 11
    Dec
MRNA Moderna
$427.66 /

+8.15 (+1.94%)

MRNA Moderna
$427.66 /

+8.15 (+1.94%)

ABCL AbCellera
$17.56 /

-0.19 (-1.07%)

MRNA Moderna
$427.66 /

+8.15 (+1.94%)

ABCL AbCellera
$17.56 /

-0.19 (-1.07%)

Hot Stocks
AbCellera acquires biotechnology firm TetraGenetics in all cash transaction » 09:05
09/13/21
09/13
09:05
09/13/21
09:05
ABCL

AbCellera

$18.98 /

+0.56 (+3.04%)

AbCellera announced it…

AbCellera announced it has acquired TetraGenetics , a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes an upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to successfully developed therapeutics. TetraGenetics has leading technology and expertise in the expression and purification of ion channels, G protein-coupled receptors, GPCR, and other transmembrane proteins, which are implicated in many human diseases, including pain and autoimmune disorders. High-value transmembrane proteins have proven extremely difficult to produce, making the generation of antibodies against them even more challenging. TetraGenetics has established a protein expression platform that addresses these production challenges and is uniquely able to generate highly pure, complex transmembrane proteins in quantities large enough to support antibody discovery. Integrating TetraGenetics' capabilities into AbCellera's technology stack provides an optimized protein source for AbCellera's antibody discovery. Together, these technologies have the potential to unlock the discovery of antibodies against these validated and sought-after drug targets.

ShowHide Related Items >><<
ABCL AbCellera
$18.98 /

+0.56 (+3.04%)

ABCL AbCellera
$18.98 /

+0.56 (+3.04%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
ABCL AbCellera
$18.98 /

+0.56 (+3.04%)

  • 11
    Dec
ABCL AbCellera
$18.98 /

+0.56 (+3.04%)

ABCL AbCellera
$18.98 /

+0.56 (+3.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.